Rate My Professor Ravinay Bhindi
.webp){kind=logo}
Ratings & reviews
Encourages critical thinking and analysis.
Brings energy and passion to every lesson.
A master at fostering understanding.
Encourages students to think outside the box.
Great Professor!
Taught by or worked with Ravinay?
Add your rating. It takes about 30 seconds.
About Ravinay
Professor Ravinay Bhindi is an Interventional Cardiologist, Professor of Medicine at the University of Sydney, and consultant at Royal North Shore Hospital, a teaching hospital of Sydney Medical School. He graduated with a Bachelor of Medicine and Bachelor of Surgery (MBBS) from the University of Sydney in 1998 and earned his PhD in Medicine from the same institution in 2007. Additionally, he holds a Master of Science (MSc) from the University of Oxford, obtained after completing further interventional cardiology training and a postdoctoral fellowship at the John Radcliffe Hospital, University of Oxford. Bhindi is a Fellow of the Royal Australasian College of Physicians (FRACP), the Cardiac Society of Australia and New Zealand (FCSANZ), and the European Society of Cardiology (FESC). In his clinical roles, he serves as Head of Cardiology at Royal North Shore Hospital, Head of Clinical Trials, and Head of Structural Heart Disease at both Royal North Shore Hospital and North Shore Private Hospital. His expertise lies in complex coronary interventions and structural heart disease, particularly percutaneous valve therapies such as transcatheter aortic valve implantation (TAVI).
Bhindi maintains active research programs with interests in cardiology, valvular heart disease, cardiovascular disease, coronary artery disease, acute coronary syndrome, myocardial infarction, and percutaneous coronary intervention (PCI). Current projects include developing machine learning algorithms for risk prediction in critical cardiovascular conditions, assessing extended cardiac rhythm monitoring post-TAVI to prevent delayed heart block and reduce readmissions, and evaluating same-day discharge feasibility for low-risk TAVI patients—the first prospective Australian study on this topic. He has authored 392 publications listed on ResearchGate, garnering 8,183 citations and 41,584 reads. Key publications encompass "Cardiovascular drug development: role of Mendelian randomization" (2026), "Health-Related Quality-of-Life and its Determinants After Acute Coronary Syndrome Caused by Spontaneous Coronary Artery Dissection" (2026), "Spontaneous Coronary Artery Dissection: Sex Differences in Clinical Presentation and Outcomes From the Australian New Zealand Registry" (2026), "Development and validation of a machine learning model for prediction of 1-year mortality following ST-elevation myocardial infarction: a retrospective cohort study" (2026), and "Incidence and Predictors of Pacemaker Implantation Post-Transcatheter Aortic Valve Replacement in Patients with Pre-existing Right Bundle-Branch Block" (2026). Bhindi received the Sydney Medical School Foundation Chapman Fellowship and the RACP Fellows Career Development Fellowship in 2016.
Trending Research & Publication News
SPARC Cost of Knowledge Study: 95% Public Investment in Articles
Photo by Precondo CA on Unsplash
AI Research Scooping: OpenAI & Anthropic Priority Disputes
Photo by Brecht Corbeel on Unsplash
Informa Taylor & Francis Split & Clarion Deal | AcademicJobs
Photo by Anne Nygård on Unsplash
arXiv Two-Submission Monthly Cap Explained | AcademicJobs
Photo by Kelly Sikkema on Unsplash
Cell Press Bribery Investigation: Cancer Cell Editor Accused
Photo by Markus Winkler on Unsplash
Society Journal Sales & Nonprofit Consolidations | AcademicJobs
Photo by Philip Strong on Unsplash